Your browser is no longer supported. Please, upgrade your browser.
Settings
BSGM [NASD]
BioSig Technologies, Inc.
Index- P/E- EPS (ttm)-1.04 Insider Own5.30% Shs Outstand34.86M Perf Week-14.61%
Market Cap99.60M Forward P/E- EPS next Y-0.76 Insider Trans1.50% Shs Float30.67M Perf Month-15.43%
Income-33.60M PEG- EPS next Q-0.23 Inst Own13.60% Short Float6.73% Perf Quarter-14.61%
Sales0.40M P/S249.00 EPS this Y-13.70% Inst Trans-2.99% Short Ratio9.22 Perf Half Y-31.69%
Book/sh0.52 P/B5.06 EPS next Y20.60% ROA-142.00% Target Price13.00 Perf Year-43.32%
Cash/sh0.46 P/C5.69 EPS next 5Y- ROE-175.50% 52W Range2.26 - 6.14 Perf YTD-32.56%
Dividend- P/FCF- EPS past 5Y-1.50% ROI- 52W High-57.17% Beta1.60
Dividend %- Quick Ratio7.00 Sales past 5Y- Gross Margin54.00% 52W Low16.37% ATR0.27
Employees49 Current Ratio7.80 Sales Q/Q- Oper. Margin- RSI (14)41.32 Volatility9.47% 8.58%
OptionableYes Debt/Eq0.00 EPS Q/Q45.70% Profit Margin- Rel Volume0.90 Prev Close2.82
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume223.95K Price2.63
Recom2.00 SMA20-17.73% SMA50-8.84% SMA200-24.95% Volume201,789 Change-6.74%
Mar-30-20Initiated ROTH Capital Buy $9
Dec-01-21 09:25AM  
Nov-17-21 09:45AM  
Nov-16-21 09:52AM  
Nov-11-21 02:45PM  
Nov-10-21 09:20AM  
Nov-08-21 11:30AM  
Nov-04-21 11:00AM  
Nov-01-21 12:30PM  
Oct-13-21 09:01AM  
Oct-12-21 09:15AM  
Oct-07-21 12:41PM  
Oct-04-21 08:30AM  
Sep-28-21 09:15AM  
Sep-23-21 09:47AM  
06:43AM  
Sep-21-21 10:30AM  
Sep-17-21 07:40AM  
Sep-13-21 08:00AM  
Sep-02-21 09:41AM  
Aug-31-21 10:00AM  
Aug-19-21 11:00AM  
Jul-20-21 02:00PM  
Jul-13-21 02:30PM  
Jul-12-21 10:30AM  
Jul-07-21 04:10PM  
09:36AM  
Jul-06-21 09:44AM  
Jul-02-21 09:37AM  
08:15AM  
Jul-01-21 04:05PM  
Jun-30-21 10:03AM  
09:35AM  
Jun-28-21 09:45AM  
Jun-22-21 10:06AM  
Jun-15-21 02:14PM  
08:30AM  
Jun-07-21 08:30AM  
May-28-21 10:30AM  
May-24-21 09:44AM  
May-21-21 09:15AM  
May-04-21 06:28PM  
09:15AM  
May-03-21 12:00PM  
01:56AM  
Apr-27-21 09:30AM  
Apr-15-21 11:45AM  
Apr-14-21 09:29AM  
Apr-13-21 09:32AM  
Apr-09-21 09:32AM  
Apr-08-21 09:32AM  
Apr-06-21 09:45AM  
Apr-05-21 10:00AM  
Mar-30-21 08:30AM  
Mar-29-21 09:15AM  
Mar-19-21 12:15PM  
Mar-10-21 05:30PM  
Mar-09-21 04:45PM  
Mar-05-21 09:44AM  
Mar-04-21 09:15AM  
Feb-16-21 08:45AM  
Feb-11-21 08:30AM  
Feb-10-21 10:00AM  
Feb-08-21 08:35AM  
Feb-02-21 08:00AM  
Jan-28-21 08:35AM  
Jan-27-21 04:30PM  
Jan-15-21 09:32AM  
Jan-14-21 09:32AM  
Jan-13-21 01:35PM  
09:32AM  
07:00AM  
Jan-12-21 09:32AM  
Jan-11-21 12:13AM  
Jan-06-21 10:00AM  
Dec-18-20 08:30AM  
Dec-16-20 09:45AM  
Dec-11-20 07:51AM  
07:30AM  
Dec-10-20 03:00PM  
Dec-03-20 11:00AM  
Dec-02-20 11:41AM  
Nov-30-20 11:00AM  
Nov-19-20 11:32AM  
Nov-12-20 02:11PM  
05:56AM  
Oct-29-20 02:05PM  
Oct-28-20 10:00AM  
Oct-26-20 11:04AM  
07:30AM  
Sep-30-20 09:27AM  
Sep-22-20 10:55AM  
Sep-21-20 11:01AM  
Sep-15-20 10:00AM  
Sep-14-20 03:00PM  
10:29AM  
Sep-09-20 12:15PM  
Sep-02-20 10:15AM  
Aug-31-20 05:00PM  
Aug-25-20 10:45AM  
08:30AM  
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LONDONER KENNETH LChief Executive OfficerSep 21Buy2.855,95016,9581,719,244Sep 29 01:56 PM
LONDONER KENNETH LChief Executive OfficerSep 20Buy2.812,6367,4071,713,294Sep 29 01:56 PM
LONDONER KENNETH LChief Executive OfficerSep 02Buy3.091,2003,7131,710,658Sep 02 12:56 PM
LONDONER KENNETH LChief Executive OfficerSep 01Buy3.104,40013,6241,709,458Sep 02 12:56 PM
LONDONER KENNETH LChief Executive OfficerSep 01Buy3.096,40019,8021,705,058Sep 01 12:48 PM
LONDONER KENNETH LChief Executive OfficerAug 30Buy3.029,00027,1941,698,658Aug 31 10:00 AM
CHAUSSY STEVEChief Financial OfficerMay 21Buy3.382,0006,770833,128May 24 04:17 PM
ODONNELL JEFFREY FDirectorFeb 08Sale5.1242,762219,100151,629Feb 09 09:15 PM
ODONNELL JEFFREY FDirectorFeb 05Sale5.0062,238311,271194,391Feb 09 09:15 PM